Epigenetic profiles of blood cancer cells could aid in diagnosis and treatment

Research in biomedical laboratories has been changing significantly in recent years, to the point that test tubes have given way to computers on many occasions.

First study to report isolation of M. saskatchewanense from medical devices

Researchers reported the first isolation of M. saskatchewanense from medical-grade equipment.

December 12, 2023

Boston Scientific to buy vascular device maker for $1.16 billion

Boston Scientific said on Tuesday it will buy Silk Road Medical, a medical device company treating stroke, for $1.16 billion. Silk Road Medical sells technology

June 18, 2024

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu

Share this article In the DESTINY-PanTumor02 trial, subjects treated with Daiichi Sankyo-AstraZeneca’s Enhertu achieved a confirmed ORR of 51.4%. Credit: Anna in Sweden / Shutterstock.com.

April 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.